Sachdev Amit
EVP Chief Patient & Ext Af Off
Sachdev Amit has filed 7 SEC Form 4 filings (19 transaction rows) across 1 company, with disclosures dating back to 2026. 7 of those filings fall inside the rolling window. Most recent filing: Jul 23, 2026.
On the most recent filing, Sachdev Amit is listed as EVP Chief Patient & Ext Af Off at VERTEX PHARMACEUTICALS INC / MA. Inside the rolling window, Sachdev Amit reported no open-market purchases and 2 open-market sales totaling $28.4M in VRTX. The largest disclosed transaction in the window is a sale of 58,613 VRTX shares on Feb 19, 2026, worth $27.5M.
Companies traded
Other insiders at VRTX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$28.4M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Sachdev Amit made?
Sachdev Amit has filed 7 SEC Form 4 filings (19 transaction rows) across 1 company since 2026.
Which companies does Sachdev Amit trade?
Sachdev Amit has filed SEC Form 4 disclosures for 1 company, including VRTX.
When was Sachdev Amit's most recent SEC Form 4 filing?
Sachdev Amit's most recent SEC Form 4 filing on Tracefour is dated Jul 23, 2026.
What is Sachdev Amit's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Sachdev Amit is listed as EVP Chief Patient & Ext Af Off.
What is Sachdev Amit's total buy and sell value in the current window?
Inside the rolling retention window, Sachdev Amit bought $0 and sold $28.4M based on SEC Form 4 filings.
What was Sachdev Amit's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 58,613 VRTX shares on 2026-02-19, worth $27.5M, per SEC Form 4 filings.